-
1دورية أكاديميةBudget Impact Of Eltrombopag As First-Line Treatment For Severe Aplastic Anemia In The United States
المؤلفون: Tremblay,Gabriel, Said,Qayyim, Roy,Anuja Nidumolu, Cai,Beilei, Ashton Garib,Shan, Hearnden,Jaclyn, Forsythe,Anna
مصطلحات موضوعية: ClinicoEconomics and Outcomes Research
وصف الملف: text/html
-
2دورية أكاديميةBudget Impact Of Eltrombopag As First-Line Treatment For Severe Aplastic Anemia In The United States
المؤلفون: Tremblay, Gabriel, Said, Qayyim, Roy, Anuja Nidumolu, Cai, Beilei, Ashton Garib, Shan, Hearnden, Jaclyn, Forsythe, Anna
المصدر: ClinicoEconomics and Outcomes Research ; volume Volume 11, page 673-681 ; ISSN 1178-6981
الإتاحة: https://doi.org/10.2147/ceor.s226323Test
https://www.dovepress.com/getfile.php?fileID=53911Test -
3دورية أكاديمية
المساهمون: Novartis Pharmaceuticals Corporation
المصدر: Clinical Therapeutics ; volume 42, issue 5, page 860-872.e8 ; ISSN 0149-2918
مصطلحات موضوعية: Pharmacology (medical), Pharmacology
الإتاحة: https://doi.org/10.1016/j.clinthera.2020.02.020Test
https://api.elsevier.com/content/article/PII:S0149291820301223?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0149291820301223?httpAccept=text/plainTest -
4دورية
المؤلفون: Forsythe, Anna, Schneider, John, Pham, Timothy, Bhor, Menaka, Said, Qayyim, Allepuz, Alejandro, Socorro O Portella, Maria do, Kwon, Christina S, Roy, Anuja Nidumolu
المصدر: Journal of Comparative Effectiveness Research; March 2020, Vol. 9 Issue: 7 p447-457, 11p